Fanconi anemia: Genetic analysis of a human disease using chicken system

Cytogenetic and Genome Research

Volumn 117, Issue 1-4, 2007, Pages 346-351

  Takata, M ^a   Kitao, H ^a   Ishiai, M ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW DEPRESSION; CANCER INCIDENCE; CHICKEN; CHROMATID EXCHANGE; CHROMOSOME BREAKAGE; DNA CROSS LINKING; DNA RECOMBINATION; DNA REPAIR; FANCONI ANEMIA; GENE MUTATION; GENETIC ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SKELETON MALFORMATION;

ANIMALS; CELL LINE; CELL SEPARATION; CHICKENS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HUMANS; RAD51 RECOMBINASE; RECOMBINATION, GENETIC;

EID: 34547634597     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103197     Document Type: Article

References (53)

1. Arakawa H, Buerstedde JM: Immunoglobulin gene conversion: Insights from bursal B cells and the DT40 cell line. Dev Dyn 229:458-464 (2004).
2. Arakawa H, Saribasak H, Buerstedde JM: Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate. PLoS Biol 2:E179 (2004).
3. -/- mutant of the chicken DT40 cell line. Cell 89:185-193 (1997).
4. Bridge WL, Vandenberg CJ, Franklin RJ, Hiom K: The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat Genet 37:953-957 (2005).
5. Buerstedde JM, Takeda S: Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 67:179-188 (1991).
6. Buerstedde JM, Reynaud CA, Humphries EH, Olson W, Ewert DL, Weill JC: Light chain gene conversion continues at high rate in an ALV-induced cell line. EMBO J 9:921-927 (1990).
7. Cox MM: Recombinational DNA repair of damaged replication forks in Escherichia coli: questions. Annu Rev Genet 35:53-82 (2001).
8. Cox MM, Goodman MF, Kreuzer KN, Sherratt DJ, Sandler SJ, Marians KJ: The importance of repairing stalled replication forks. Nature 404:37-41 (2000).
9. D'Andrea AD, Grompe M: The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 3:23-34 (2003).
10. Fujimori A, Tachiiri S, Sonoda E, Thompson LH, Dhar PK, et al: Rad52 partially substitutes for the Rad51 paralog XRCC3 in maintaining chromosomal integrity in vertebrate cells. EMBO J 20:5513-5520 (2001).
11. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, et al: Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7:249-262 (2001).
12. Hickson ID: RecQ helicases: caretakers of the genome. Nat Rev Cancer 3:169-178 (2003).
13. Hinz JM, Nham PB, Salazar EP, Thompson LH: The Fanconi anemia pathway limits the severity of mutagenesis. DNA Repair (Amst) 5:875-884 (2006).
14. Hirano S, Yamamoto K, Ishiai M, Yamazoe M, Seki M, et al: Functional relationships of FANCC to homologous recombination translesion synthesis and BLM. EMBO J 24:418-427 (2005).
15. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, et al: Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297:606-609 (2002).
16. Hussain S, Witt E, Huber PA, Medhurst AL, Ashworth A, Mathew CG: Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet 12:2503-2510 (2003).
17. Johnson RD, Liu N, Jasin M: Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination. Nature 401:397-399 (1999).
18. Kannouche PL, Wing J, Lehmann AR: Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol Cell 14:491-500 (2004).
19. Kitao H, Yamamoto K, Matsushita N, Ohzeki, M Ishiai M, Takata M: Functional interplay between BRCA2/FANCD1 and FANCC in DNA repair. J Biol Chem 281:21312-21320 (2006).
20. Komori K, Fujikane R, Shinagawa H, Ishino Y: Novel endonuclease in Archaea cleaving DNA with various branched structure. Genes Genet Syst 77:227-241 (2002).
21. Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, et al: Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 103:2498-2503 (2004).
22. Levitus M, Waisfisz Q, Godthelp BC, Vries Y, Hussain S, et al: The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J Nat Genet 37:934-935 (2005).
23. Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, et al: The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37:931-933 (2005).
24. Litman R, Peng M, Jin Z, Zhang F, Zhang J, et al: BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8:255-265 (2005).
25. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, et al: A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 35:165-170 (2003a).
26. Meetei AR, Sechi S, Wallisch M, Yang D, Young MK, et al: A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol 23:3417-3426 (2003b).
27. Meetei AR, Levitus M, Xue Y, Medhurst AL, Zwaan M, et al: X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 36:1219-1224 (2004).
28. Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, et al: A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 37:958-963 (2005).
29. Mosedale G, Niedzwiedz W, Alpi A, Perrina F, Pereira-Leal JB, Jet al: The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat Struct Mol Biol 12:763-771 (2005).
30. Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, et al: Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 4:913-920 (2002).
31. Niedzwiedz W, Mosedale G, Johnson M, Ong CY, Pace P, Patel KJ: The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol Cell 15:607-620 (2004).
32. Paques F, Haber JE: Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 63:349-404 (1999).
33. Park WH, Margossian S, Horwitz AA, Simons AM, D'Andrea AD, Parvin JD: Direct DNA binding activity of the Fanconi anemia D2 protein. J Biol Chem 280:23593-23598 (2005).
34. Prakash S, Johnson RE, Prakash L: Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem 74:317-353 (2005).
35. Sasaki MS: Is Fanconi's anaemia defective in a process essential to the repair of DNA cross links? Nature 257:501-503 (1975).
36. Sasaki MS, Tonomura A: A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 33:1829-1836 (1973)
37. Simpson LJ, Sale JE: Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J 22:1654-1664 (2003).
38. Sonoda E, Sasaki MS, Buerstedde JM, Bezzubova O, Shinohara A, et al: Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J 17:598-608 (1998).
39. Sonoda E, Sasaki MS, Morrison C, Yamaguchi-Iwai Y, Takata M, Takeda S: Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol Cell Biol 19:5166-5169 (1999).
40. Sonoda E, Takata M, Yamashita YM, Morrison C, Takeda S: Homologous DNA recombination in vertebrate cells. Proc Natl Acad Sci USA 98:8388-8394 (2001).
41. Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ: MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421:961-966 (2003).
42. Takata M, Sasaki MS, Sonoda E, Fukushima T, Morrison C, et al: The Rad51 paralog Rad51B promotes homologous recombinational repair. Mol Cell Biol 20:6476-6482 (2000).
43. Takata M, Sasaki MS, Tachiiri S, Fukushima T, Sonoda E, et al: Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol 21:2858-2866 (2001).
44. Taniguchi T, D'Andrea AD: Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107:4223-4233 (2006).
45. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD: S-phase-specific interaction of the Fanconi anemia protein FANCD2 with BRCA1 and RAD51. Blood 100:2414-2420 (2002).
46. Thompson LH, Hinz JM, Yamada NA, Jones NJ: How Fanconi anemia proteins promote the four Rs: Replication recombination repair and recovery. Environ Mol Mutagen 45:128-142 (2005).
47. Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171-182 (2002).
48. Wang X, Andreassen PR, D'Andrea AD: Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 24:5850-5862 (2004).
49. Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, Yamaizumi M: Rad18 guides polWη to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J 23:3886-3896 (2004).
50. West SC: Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol 4:435-445 (2003).
51. Yamamoto K, Hirano S, Ishiai M, Morishima K, Kitao H, et al: Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol Cell Biol 25:34-43 (2005).
52. Yamamoto K, Ishiai M, Matsushita N, Arakawa H, Lamerdin JE, et al: Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol Cell Biol 23:5421-5430 (2003).
53. Yu X, Chini CC, He M, Mer G, Chen J: The BRCT domain is a phospho-protein binding domain. Science 302:639-642 (2003).